Deflazacort in pharma franchise in Kerala

Deflazacort in PCD pharma franchise in Hyderabad

Deflazacort in top pharma company in Nashik

Deflazacort in pcd pharma supplier in Kochi

Deflazacort in phama franchise company in India
Deflazacort in phama distributor in Aizawl

Home/Products /deflazacort-30mg-tablet

Defziff 30 Tablet

Composition : Deflazacort (30mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹515/-

Defziff 30 Tablet, containing 30 mg of deflazacort, is a corticosteroid medication primarily used to manage various inflammatory and autoimmune conditions. This powerful drug is effective in reducing inflammation and suppressing the immune response, making it suitable for treating conditions such as rheumatoid arthritis, systemic lupus erythematosus, and certain skin disorders. Defziff can also be beneficial in managing severe allergies and certain types of cancer as part of a comprehensive treatment plan.

Deflazacort works by inhibiting the production of substances that trigger inflammation and immune responses. Its rapid onset of action makes it a preferred choice for patients needing prompt relief from symptoms. Additionally, Defziff is sometimes used to treat Duchenne muscular dystrophy in pediatric patients, offering hope for improved muscle function and quality of life.

While Defziff 30 Tablet can provide significant therapeutic benefits, it is essential to be aware of potential side effects. Common side effects include weight gain, increased appetite, mood changes, and gastrointestinal disturbances. More serious side effects, though less common, may involve elevated blood sugar levels, increased risk of infections, and bone density loss with long-term use. Regular monitoring by a healthcare professional is crucial to manage these risks effectively.

Read More

About the Product

Defziff 30 Tablet, containing 30 mg of deflazacort, is a corticosteroid medication primarily used to manage various inflammatory and autoimmune conditions. This powerful drug is effective in reducing inflammation and suppressing the immune response, making it suitable for treating conditions such as rheumatoid arthritis, systemic lupus erythematosus, and certain skin disorders. Defziff can also be beneficial in managing severe allergies and certain types of cancer as part of a comprehensive treatment plan.

Deflazacort works by inhibiting the production of substances that trigger inflammation and immune responses. Its rapid onset of action makes it a preferred choice for patients needing prompt relief from symptoms. Additionally, Defziff is sometimes used to treat Duchenne muscular dystrophy in pediatric patients, offering hope for improved muscle function and quality of life.

While Defziff 30 Tablet can provide significant therapeutic benefits, it is essential to be aware of potential side effects. Common side effects include weight gain, increased appetite, mood changes, and gastrointestinal disturbances. More serious side effects, though less common, may involve elevated blood sugar levels, increased risk of infections, and bone density loss with long-term use. Regular monitoring by a healthcare professional is crucial to manage these risks effectively.

Possible side effects include weight gain, mood changes, and gastrointestinal issues.

Defziff 30 is indicated for inflammatory and autoimmune conditions, including rheumatoid arthritis and lupus.

Consult a healthcare provider before use, especially if you have pre-existing health conditions or are pregnant.

Store at room temperature, away from moisture and heat.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation